HTG MOLECULAR DIAGNOSTICS, INC·4

Jan 27, 4:37 PM ET

Lubniewski John L 4

4 · HTG MOLECULAR DIAGNOSTICS, INC · Filed Jan 27, 2020

Insider Transaction Report

Form 4
Period: 2020-01-23
Lubniewski John L
Chief Business Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-01-23+537,500537,500 total
    Exercise: $0.66Exp: 2030-01-22Common Stock (537,500 underlying)
Footnotes (1)
  • [F1]The shares will vest monthly over a two year period beginning January 1, 2020 (first vesting date will be January 31) such that the shares will fully vest by December 31, 2021.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION